Entero Healthcare Solutions Stock Current Valuation
| ENTERO Stock | 1,313 8.10 0.61% |
Valuation analysis of Entero Healthcare helps investors to measure Entero Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Entero Healthcare's Cash is projected to increase significantly based on the last few years of reporting. The current year's Cash And Short Term Investments is expected to grow to about 9.5 B, whereas Free Cash Flow is forecasted to decline to (507.5 M). Fundamental drivers impacting Entero Healthcare's valuation include:
Price Book 3.4892 | Enterprise Value 52.7 B | Enterprise Value Ebitda 38.2992 | Price Sales 1.3833 | Trailing PE 107.5491 |
Overvalued
Today
Please note that Entero Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Entero Healthcare is based on 3 months time horizon. Increasing Entero Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Entero Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Entero Stock. However, Entero Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1312.7 | Real 1146.15 | Hype 1312.7 |
The real value of Entero Stock, also known as its intrinsic value, is the underlying worth of Entero Healthcare Company, which is reflected in its stock price. It is based on Entero Healthcare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Entero Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Entero Healthcare Solutions helps investors to forecast how Entero stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Entero Healthcare more accurately as focusing exclusively on Entero Healthcare's fundamentals will not take into account other important factors: Entero Healthcare Solutions Company Current Valuation Analysis
Entero Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Entero Healthcare Current Valuation | 52.65 B |
Most of Entero Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Entero Healthcare Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Entero Healthcare Solutions has a Current Valuation of 52.65 B. This is 266.56% higher than that of the Health Care Providers & Services sector and 297.4% higher than that of the Health Care industry. The current valuation for all India stocks is significantly lower than that of the firm.
Entero Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Entero Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Entero Healthcare could also be used in its relative valuation, which is a method of valuing Entero Healthcare by comparing valuation metrics of similar companies.Entero Healthcare is currently under evaluation in current valuation category among its peers.
Entero Fundamentals
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 52.65 B | ||||
| Shares Outstanding | 43.49 M | ||||
| Shares Owned By Insiders | 69.79 % | ||||
| Shares Owned By Institutions | 19.73 % | ||||
| Price To Book | 3.49 X | ||||
| Price To Sales | 1.38 X | ||||
| Revenue | 39.22 B | ||||
| EBITDA | 1.26 B | ||||
| Net Income | 355.55 M | ||||
| Total Debt | 3.38 B | ||||
| Book Value Per Share | 376.62 X | ||||
| Cash Flow From Operations | (366.12 M) | ||||
| Earnings Per Share | 12.22 X | ||||
| Target Price | 1509.33 | ||||
| Number Of Employees | 3.24 K | ||||
| Market Capitalization | 57.16 B | ||||
| Total Asset | 23.45 B | ||||
| Retained Earnings | (338.07 M) | ||||
| Net Asset | 23.45 B |
About Entero Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Entero Healthcare Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Entero Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Entero Healthcare Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Entero Stock
Entero Healthcare financial ratios help investors to determine whether Entero Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entero with respect to the benefits of owning Entero Healthcare security.